The mean weight of tumours formed by PAX5‐transfected cells was significantly lower than that of vector control formed tumours (Fig. 6C, P < 0.05), indicating that PAX5 can inhibit NSCLC cell grow tumours in vivo. The gene discussed is PAX5; the disease is non-small cell lung carcinoma.